Thomas Ferkol

1.4k total citations · 1 hit paper
25 papers, 624 citations indexed

About

Thomas Ferkol is a scholar working on Pulmonary and Respiratory Medicine, Emergency Medical Services and Surgery. According to data from OpenAlex, Thomas Ferkol has authored 25 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 7 papers in Emergency Medical Services and 4 papers in Surgery. Recurrent topics in Thomas Ferkol's work include Cystic Fibrosis Research Advances (13 papers), Pediatric health and respiratory diseases (7 papers) and Tracheal and airway disorders (5 papers). Thomas Ferkol is often cited by papers focused on Cystic Fibrosis Research Advances (13 papers), Pediatric health and respiratory diseases (7 papers) and Tracheal and airway disorders (5 papers). Thomas Ferkol collaborates with scholars based in United States, Canada and Australia. Thomas Ferkol's co-authors include Dean E. Schraufnagel, Kristie Ross, James F. Chmiel, Stephanie D. Davis, Jean Eastman, Stephen M. Stick, James E. Slaven, Bradley J. Segura, Gregory A. Storch and Matthew D. Smyth and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Thomas Ferkol

19 papers receiving 606 citations

Hit Papers

The Global Burden of Respiratory Disease 2014 2026 2018 2022 2014 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Ferkol United States 8 276 113 101 93 66 25 624
Eduardo Márquez Martín Spain 14 463 1.7× 204 1.8× 90 0.9× 30 0.3× 86 1.3× 73 811
Zbigniew Doniec Poland 12 165 0.6× 104 0.9× 40 0.4× 22 0.2× 36 0.5× 55 445
Edgar Delgado‐Eckert Switzerland 12 136 0.5× 104 0.9× 50 0.5× 40 0.4× 36 0.5× 33 391
Andrzej Chciałowski Poland 16 128 0.5× 107 0.9× 65 0.6× 95 1.0× 69 1.0× 71 562
Tetyana Zakharkina Germany 10 216 0.8× 95 0.8× 104 1.0× 17 0.2× 223 3.4× 10 636
Yixiao Bao China 16 123 0.4× 193 1.7× 119 1.2× 79 0.8× 73 1.1× 38 653
Matthew Richardson United Kingdom 15 406 1.5× 339 3.0× 112 1.1× 23 0.2× 104 1.6× 48 820
O. U. Soyer Türkiye 18 259 0.9× 572 5.1× 60 0.6× 62 0.7× 124 1.9× 43 1.0k
Jayesh Bhatt United Kingdom 16 583 2.1× 159 1.4× 121 1.2× 24 0.3× 171 2.6× 62 869
Philip Diaz United States 12 707 2.6× 204 1.8× 178 1.8× 81 0.9× 261 4.0× 23 1.2k

Countries citing papers authored by Thomas Ferkol

Since Specialization
Citations

This map shows the geographic impact of Thomas Ferkol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Ferkol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Ferkol more than expected).

Fields of papers citing papers by Thomas Ferkol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Ferkol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Ferkol. The network helps show where Thomas Ferkol may publish in the future.

Co-authorship network of co-authors of Thomas Ferkol

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Ferkol. A scholar is included among the top collaborators of Thomas Ferkol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Ferkol. Thomas Ferkol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Li, et al.. (2026). Tidal Breathing Nasal Nitric Oxide Measurement as a Test for Primary Ciliary Dyskinesia in Young Children. European Respiratory Journal. 2501540–2501540.
2.
Wang, Wangfei, Christian Ascoli, Joseph Hatch, et al.. (2025). An observational study of the lung microbiome and lung function in young children with cystic fibrosis across two countries with differing antibiotic practices. Microbial Pathogenesis. 205. 107628–107628.
3.
Sullivan, Kelli M., Brian D. Thorp, Thomas Ferkol, et al.. (2025). Advances in Sinonasal Microbiome Analysis. Ear Nose & Throat Journal. 1590087055–1590087055.
4.
Rosenfeld, Margaret, Erin Sullivan, Frankline Onchiri, et al.. (2024). Comparison of Longitudinal Outcomes in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis. Annals of the American Thoracic Society. 21(12). 1723–1732. 1 indexed citations
5.
Gardner, Robert A., Thomas Ferkol, Stephanie D. Davis, et al.. (2024). Therapies Used by Children With Primary Ciliary Dyskinesia: A Natural History Study. Pediatric Pulmonology. 60(1). e27412–e27412. 2 indexed citations
6.
Ferkol, Thomas. (2024). Understanding primary ciliary dyskinesia. Pediatric Pulmonology. 60(S1). S86–S87.
7.
Sanders, Don B., Joseph Hatch, James E. Slaven, et al.. (2022). Association between early respiratory viral infections and structural lung disease in infants with cystic fibrosis. Journal of Cystic Fibrosis. 21(6). 1020–1026. 6 indexed citations
8.
Bush, Andrew, et al.. (2021). Unfriendly Fire: How the Tobacco Industry is Destroying the Future of Our Children. SHILAP Revista de lepidopterología. 28(1). 6–18. 3 indexed citations
9.
Hatch, Joseph, James E. Slaven, Gregory A. Storch, et al.. (2019). Early respiratory viral infections in infants with cystic fibrosis. Journal of Cystic Fibrosis. 18(6). 844–850. 28 indexed citations
10.
North, Crystal M., Mary B. Rice, Thomas Ferkol, et al.. (2018). Air Pollution in the Asia-Pacific Region. A Joint Asian Pacific Society of Respirology/American Thoracic Society Perspective. American Journal of Respiratory and Critical Care Medicine. 199(6). 693–700. 13 indexed citations
11.
Dell, Sharon, Margaret W. Leigh, Thomas Ferkol, et al.. (2014). Development of pediatric cross-cultural patient-reported outcome measures: QOL-PCD. European Respiratory Journal. 44(Suppl 58). P1248–P1248. 6 indexed citations
12.
Ferkol, Thomas & Dean E. Schraufnagel. (2014). The Global Burden of Respiratory Disease. Annals of the American Thoracic Society. 11(3). 404–406. 449 indexed citations breakdown →
13.
Heltshe, Sonya L., Lisa Saiman, Elena B. Popowitch, et al.. (2014). Outcomes and Treatment of Chronic Methicillin-ResistantStaphylococcus aureusDiffers by Staphylococcal Cassette Chromosomemec(SCCmec) Type in Children With Cystic Fibrosis. Journal of the Pediatric Infectious Diseases Society. 4(3). 225–231. 15 indexed citations
14.
Smyth, Matthew D., et al.. (2011). Recurrent pleural effusion without intrathoracic migration of ventriculoperitoneal shunt catheter: A case report. Pediatric Pulmonology. 47(1). 91–95. 13 indexed citations
16.
Shapiro, Adam J., Stephanie D. Davis, Kenneth N. Olivier, et al.. (2010). Clinical Symptoms Associated With Primary Ciliary Dyskinesia : Results Of A Multi-Centered Study. A6728–A6728. 3 indexed citations
17.
Akers, Kathryn, et al.. (2009). Airway proteins involved in bacterial clearance susceptible to cathepsin G proteolysis. European Respiratory Journal. 35(2). 410–417. 5 indexed citations
18.
Gappa, Monika, Thomas Ferkol, Thomas Kovesi, et al.. (2009). Pediatric respiratory medicine—an international perspective. Pediatric Pulmonology. 45(1). 14–24. 4 indexed citations
19.
Müller, Christa E., Qiushi Tang, Carol J. Detrisac, et al.. (2004). Functional Characterization of a Recombinant Adeno-Associated Virus 5-Pseudotyped Cystic Fibrosis Transmembrane Conductance Regulator Vector. Human Gene Therapy. 15(9). 832–841. 5 indexed citations
20.
Eastman, Jean, et al.. (2001). Single chain Fv: a ligand in receptor-mediated gene delivery. Gene Therapy. 8(8). 586–592. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026